NCT00004213View on ClinicalTrials.gov

3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1998

Study Completion Date

January 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

triapine

Trial Locations (2)

85712

Arizona Clinical Research Center, Tucson

06520-8028

Yale Comprehensive Cancer Center, New Haven

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00004213 - 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter